Literature DB >> 9257059

The role of oxidatively modified lipoproteins in lipid nephropathy.

H J Gröne1, A K Walli, E F Gröne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9257059     DOI： 10.1159/000059835

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  3 in total

Review 1.  Role of triglyceride-rich lipoproteins in diabetic nephropathy.

Authors:  John C Rutledge; Kit F Ng; Hnin H Aung; Dennis W Wilson
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

2.  Expression and function of C/EBP homology protein (GADD153) in podocytes.

Authors:  Martin F Bek; Michael Bayer; Barbara Müller; Stefan Greiber; Detlef Lang; Albrecht Schwab; Christian August; Erik Springer; Rolf Rohrbach; Tobias B Huber; Thomas Benzing; Hermann Pavenstädt
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

Review 3.  Lipids and diabetic renal disease.

Authors:  Mark E Cooper; Karin A M Jandeleit-Dahm
Journal:  Curr Diab Rep       Date:  2005-12       Impact factor: 4.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.